Pain — Effects of Intranasal Oxytocin Administration on Social Influence Effects on Pain
Citation(s)
Alvares GA, Hickie IB, Guastella AJ Acute effects of intranasal oxytocin on subjective and behavioral responses to social rejection. Exp Clin Psychopharmacol. 2010 Aug;18(4):316-21. doi: 10.1037/a0019719.
Balleine BW, Dickinson A Goal-directed instrumental action: contingency and incentive learning and their cortical substrates. Neuropharmacology. 1998 Apr-May;37(4-5):407-19. Review.
Balleine BW, O'Doherty JP Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action. Neuropsychopharmacology. 2010 Jan;35(1):48-69. doi: 10.1038/npp.2009.131. Review.
Bryant RA, Hung L, Guastella AJ, Mitchell PB Oxytocin as a moderator of hypnotizability. Psychoneuroendocrinology. 2012 Jan;37(1):162-6. doi: 10.1016/j.psyneuen.2011.05.010. Epub 2011 Jun 8.
Ge Y, Lundeberg T, Yu LC Blockade effect of mu and kappa opioid antagonists on the anti-nociception induced by intra-periaqueductal grey injection of oxytocin in rats. Brain Res. 2002 Feb 15;927(2):204-7.
Guastella AJ, Howard AL, Dadds MR, Mitchell P, Carson DS A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology. 2009 Jul;34(6):917-23. doi: 10.1016/j.psyneuen.2009.01.005. Epub 2009 Feb 25.
Guastella AJ, Mitchell PB, Mathews F Oxytocin enhances the encoding of positive social memories in humans. Biol Psychiatry. 2008 Aug 1;64(3):256-8. doi: 10.1016/j.biopsych.2008.02.008. Epub 2008 Mar 17.
Heinrichs M, Baumgartner T, Kirschbaum C, Ehlert U Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol Psychiatry. 2003 Dec 15;54(12):1389-98.
Kirsch I Conditioning, expectancy, and the placebo effect: comment on Stewart-Williams and Podd (2004). Psychol Bull. 2004 Mar;130(2):341-3; discussion 344-5.
MacDonald E, Dadds MR, Brennan JL, Williams K, Levy F, Cauchi AJ A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research. Psychoneuroendocrinology. 2011 Sep;36(8):1114-26. doi: 10.1016/j.psyneuen.2011.02.015. Epub 2011 Mar 23. Review.
Montgomery GH, Kirsch I Classical conditioning and the placebo effect. Pain. 1997 Aug;72(1-2):107-13.
Morton DL, Watson A, El-Deredy W, Jones AK Reproducibility of placebo analgesia: Effect of dispositional optimism. Pain. 2009 Nov;146(1-2):194-8. doi: 10.1016/j.pain.2009.07.026. Epub 2009 Aug 18.
Ostlund SB, Balleine BW Lesions of medial prefrontal cortex disrupt the acquisition but not the expression of goal-directed learning. J Neurosci. 2005 Aug 24;25(34):7763-70.
Reeta Kh, Mediratta PK, Rathi N, Jain H, Chugh C, Sharma KK Role of kappa- and delta-opioid receptors in the antinociceptive effect of oxytocin in formalin-induced pain response in mice. Regul Pept. 2006 Jul 15;135(1-2):85-90. Epub 2006 May 19.
Rescorla RA Pavlovian conditioning. It's not what you think it is. Am Psychol. 1988 Mar;43(3):151-60.
Schoenbaum G, Roesch M Orbitofrontal cortex, associative learning, and expectancies. Neuron. 2005 Sep 1;47(5):633-6. Review.
Schoenbaum G, Roesch MR, Stalnaker TA, Takahashi YK A new perspective on the role of the orbitofrontal cortex in adaptive behaviour. Nat Rev Neurosci. 2009 Dec;10(12):885-92. doi: 10.1038/nrn2753. Epub 2009 Nov 11. Review.
Watson A, El-Deredy W, Vogt BA, Jones AK Placebo analgesia is not due to compliance or habituation: EEG and behavioural evidence. Neuroreport. 2007 May 28;18(8):771-5.
Yang J, Liang JY, Li P, Pan YJ, Qiu PY, Zhang J, Hao F, Wang DX Oxytocin in the periaqueductal gray participates in pain modulation in the rat by influencing endogenous opiate peptides. Peptides. 2011 Jun;32(6):1255-61. doi: 10.1016/j.peptides.2011.03.007. Epub 2011 Mar 23.
Zak PJ, Kurzban R, Matzner WT Oxytocin is associated with human trustworthiness. Horm Behav. 2005 Dec;48(5):522-7. Epub 2005 Aug 18.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
